<unk>  is indicated for treatment of neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME).
Faricimab
Altbib
Odesivimab
Oseltamivir
Maftivimab
Regdanvimab
Atoltivimab
Sotrovimab